| 000 | 01259 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250518004723.0 | ||
| 264 | 0 | _c20190930 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1466-609X | ||
| 024 | 7 |
_a10.1186/s13054-018-2225-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOstermann, Marlies | |
| 245 | 0 | 0 |
_aAngiotensin in ECMO patients with refractory shock. _h[electronic resource] |
| 260 |
_bCritical care (London, England) _cNov 2018 |
||
| 300 |
_a288 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAngiotensin II _xmetabolism |
| 650 | 0 | 4 |
_aAngiotensins _xmetabolism |
| 650 | 0 | 4 |
_aExtracorporeal Membrane Oxygenation _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aShock _xmetabolism |
| 650 | 0 | 4 |
_aShock, Cardiogenic _xmetabolism |
| 650 | 0 | 4 |
_aShock, Septic _xmetabolism |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xpharmacology |
| 700 | 1 | _aBoldt, David W | |
| 700 | 1 | _aHarper, Michael D | |
| 700 | 1 | _aLim, George W | |
| 700 | 1 | _aGunnerson, Kyle | |
| 773 | 0 |
_tCritical care (London, England) _gvol. 22 _gno. 1 _gp. 288 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13054-018-2225-4 _zAvailable from publisher's website |
| 999 |
_c28999489 _d28999489 |
||